No definition available.
Congenital malformations of pulmonary and tricuspid valves
Q17_CONGEN_MALFO_PULMONARY_TRICU_VALVES
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
279 |
4. Check minimum number of eventsNone |
279 |
5. Include endpointsNone |
279 |
6. Filter based on genotype QC (FinnGen only) |
279 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_CIRCULATO_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q2
- Name in latin
- Malformationes congenitae valvae (trunci) pulmonalis et valvae tricuspidalis
Similar endpoints
↥List of similar endpoints to
Congenital malformations of pulmonary and tricuspid valves
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of heart and great arteries
- Congenital malformations of the circulatory system
- Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3353 | 1847 | 1493 |
| Only index persons | 2303 | 1282 | 1021 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.05 | 0.04 |
| Only index persons | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 1.11 | 1.00 | 0.99 |
| Only index persons | 6.33 | 6.78 | 5.77 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 279 | 163 | 116 |
| Unadjusted period prevalence (%) | 0.05 | 0.06 | 0.05 |
| Median age at first event (years) | 10.49 | 14.33 | 5.08 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 261
- Matched controls
- 2602
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
+∞
193.6
161
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
82.3
93.2
102
20
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
102.0
87.6
93
14
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
18.6
87.0
155
189
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
21.6
81.6
130
114
XF400
NOMESCO Finland
ECG with 12 standard connections
12.4
64.7
138
216
201
Kela drug reimbursment
Chronic cardiac insufficiency
54.5
58.7
69
17
XF404
NOMESCO Finland
Ambulatory ECG
19.2
58.6
94
74
Q21.10
ICD-10 Finland
Persistent ostium secundum
+∞
56.3
52
*
XF402
NOMESCO Finland
ECG with work load test
20.8
52.1
80
54
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
78.5
50.6
56
9
C03DA01
ATC
spironolactone; oral
23.1
49.6
73
43
Q22.5
ICD-10 Finland
Ebstein anomaly
+∞
48.4
45
*
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
+∞
48.4
45
*
B01AA03
ATC
warfarin; systemic
18.3
46.7
75
56
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
102.5
46.7
50
6
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
14.4
45.8
82
80
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
+∞
44.0
41
*
C03CA01
ATC
furosemide; systemic
10.7
43.3
92
126
GD1AA
NOMESCO Finland
Thorax X-ray examination
6.6
43.2
157
486
FM2CE
NOMESCO Finland
NA
19.6
43.2
67
45
31
HP
Congenital heart failure surgery
+∞
42.9
40
*
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
+∞
41.8
39
*
TPH07
NOMESCO Finland
Cathetrisation of artery
12.1
41.6
81
93
I37.0
ICD-10 Finland
Pulmonary valve stenosis
+∞
39.6
37
*
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
156.3
38.9
40
*
ZXE20
NOMESCO Finland
More than three and less than five hours
8.9
38.3
91
148
Q22.0
ICD-10 Finland
Pulmonary valve atresia
+∞
37.4
35
*
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
214.0
36.8
37
*
61
HP
Catheterization and pressure measurement of the left side of the heart
214.0
36.8
37
*
C01AA05
ATC
digoxin; systemic
38.1
33.4
42
13
62
HP
Catheterization and pressure measurement of the right side of the heart
+∞
31.9
30
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
7.1
31.4
87
172
Z2221
NOMESCO Finland
Medical doctor
5.0
31.4
139
484
ZXD10
NOMESCO Finland
Scheduled procedure
4.7
30.7
159
644
WX408
NOMESCO Finland
General anesthesy, balanced
4.9
29.9
131
445
I37.1
ICD-10 Finland
Pulmonary valve insufficiency
325.6
29.4
29
*
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
80.8
26.3
29
*
Z98.8
ICD-10 Finland
Other specified postsurgical states
56.1
25.8
30
6
Q20.3
ICD-10 Finland
Discordant ventriculoarterial connection
+∞
25.4
24
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
9.1
25.4
56
76
Q20.48
ICD-10 Finland
Single ventricle
+∞
24.3
23
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
8.9
23.9
53
72
XF600
NOMESCO Finland
Bloodpressure measurement
7.0
23.4
62
111
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
91.7
23.1
25
*
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
131.3
23.0
24
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.8
22.6
134
560
WX872
NOMESCO Finland
Intensive care
20.7
22.4
33
18
WX882
NOMESCO Finland
High dependency care
7.2
22.2
57
97
Q21.30
ICD-10 Finland
Tetralogy of Fallot
+∞
22.2
21
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
18.7
21.6
33
20
XF622
NOMESCO Finland
Measurement of minute volume of heart
+∞
21.1
20
*
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
29.8
20.5
27
10
Q22.2
ICD-10 Finland
Congenital pulmonary valve insufficiency
+∞
20.0
19
*
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
+∞
20.0
19
*
7460C
ICD-9 Finland
Other congenital anomalies of heart, Anomalies of pulmonary valve[VITIUM VALVULAE PULMONALIS CONGENITA CUM STENOSIS]
+∞
20.0
19
*
Q21.19
ICD-10 Finland
Atrial septal defect NOS
+∞
20.0
19
*
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
27.1
20.0
27
11
74663
ICD-8 Finland
Congenital anomalies of heart, Stenosis valvulae pulmonalis
+∞
19.0
18
*
FXA10
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure
+∞
19.0
18
*
FJF20
NOMESCO Finland
Replacement of pulmonary valve using homograft
+∞
19.0
18
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.7
18.5
103
394
TFP20
NOMESCO Finland
Cardiodefibrillation
15.2
18.3
30
22
Q25.0
ICD-10 Finland
Patent ductus arteriosus
+∞
17.9
17
*
Q22.41
ICD-10 Finland
Tricuspid atresia
+∞
17.9
17
*
Q20.1
ICD-10 Finland
Double outlet right ventricle
+∞
17.9
17
*
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
45.4
17.5
21
5
R4110
NOMESCO Finland
Physiotherapy
3.4
17.2
106
433
XFE00
NOMESCO Finland
Epicardial ultrasonography
23.8
17.2
24
11
Q87.14
ICD-10 Finland
Noonan's syndrome
+∞
16.8
16
*
5255
FHL
Deep hypothermia (<20 °) with cardiopulmonary resuscitation
+∞
16.8
16
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
6.1
16.8
48
93
Z3231
NOMESCO Finland
Registered nurse
3.1
16.7
129
618
I48
ICD-10 Finland
Atrial fibrillation and flutter
7.0
16.6
42
69
WX892
NOMESCO Finland
Monitored bed care
5.7
16.2
49
102
FJD20
NOMESCO Finland
Bypass of pulmonary valve with ventriculopulmonary prosthesis or homograft
+∞
15.8
15
*
FBJ10
NOMESCO Finland
Anastomosis to pulmonary artery from subclavian artery with interposition graft
+∞
15.8
15
*
I37.2
ICD-10 Finland
Pulmonary valve stenosis with insufficiency
+∞
15.8
15
*
ZXD05
NOMESCO Finland
Urgent procedure
3.2
15.5
106
459
I44.2
ICD-10 Finland
Atrioventricular block, complete
47.9
15.2
18
*
ZXE00
NOMESCO Finland
One hour or less
2.9
15.1
142
759
Q25.6
ICD-10 Finland
Stenosis of pulmonary artery
+∞
14.7
14
*
Q21.32
ICD-10 Finland
Pulmonary atresia with Fallot ventricular septal defect
+∞
14.7
14
*
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
18.8
14.1
21
12
FBE32
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery
+∞
13.6
13
*
FJF10
NOMESCO Finland
Replacement of pulmonary valve using biological prosthesis
+∞
13.6
13
*
FJE42
NOMESCO Finland
Percutaneous transluminal expansion of pulmonary valve
+∞
13.6
13
*
C01BD01
ATC
amiodarone; systemic
27.4
13.5
18
7
207
Kela drug reimbursment
Chronic arrhythmias
7.3
13.3
32
49
ZXE40
NOMESCO Finland
More than seven and less than nine hours
11.3
13.0
24
23
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
5.5
12.6
38
78
Q23.11
ICD-10 Finland
Bicuspid aortic valve
+∞
12.6
12
*
FBE10
NOMESCO Finland
Expansion or reconstruction of pulmonary artery using patch
+∞
12.6
12
*
Q22.3
ICD-10 Finland
Other congenital malformations of pulmonary valve
+∞
12.6
12
*
Q25.41
ICD-10 Finland
Persistent right-sided aortic arch
+∞
12.6
12
*
1EA01
NOMESCO Finland
NA
+∞
12.6
12
*
XF620
NOMESCO Finland
Examination of circulation with color method
136.0
12.5
13
*
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
136.0
12.5
13
*
G04BE03
ATC
sildenafil; oral
24.2
11.7
16
7
Q25.78
ICD-10 Finland
Other congenital malformations of pulmonary artery
+∞
11.5
11
*
FPF20
NOMESCO Finland
Implantation of epicardial pacemaker with atrial and ventricular electrodes
+∞
11.5
11
*
Q25.1
ICD-10 Finland
Coarctation of aorta
+∞
11.5
11
*
FDF05
NOMESCO Finland
Percutaneous transluminal occlusion of aorto-pulmonary collaterals
+∞
11.5
11
*
Q22.40
ICD-10 Finland
Congenital tricuspid stenosis
+∞
11.5
11
*
FBE35
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery with insertion of stent
+∞
11.5
11
*
7AX01
NOMESCO Finland
NA
36.7
11.4
14
*
ZX120
NOMESCO Finland
Intravenous
4.4
11.0
41
106
RS224
NOMESCO Finland
NA
16.4
11.0
17
11
TPH04
NOMESCO Finland
Cathetrisation of vein
3.1
10.9
68
268
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.2
10.8
64
243
Z3226
NOMESCO Finland
Physiotherapist
2.8
10.6
83
377
C07AA07
ATC
sotalol; systemic
15.0
10.6
17
12
FFC00
NOMESCO Finland
Suture of ostium secundum type ASD
+∞
10.5
10
*
Q24.3
ICD-10 Finland
Pulmonary infundibular stenosis
+∞
10.5
10
*
Q23.10
ICD-10 Finland
Congenital insufficiency of aortic valve
+∞
10.5
10
*
Q22.6
ICD-10 Finland
Hypoplastic right heart syndrome
+∞
10.5
10
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
11.3
9.9
18
17
FM1BD
NOMESCO Finland
Extensive CT of heart
103.4
9.5
10
*
Q21.21
ICD-10 Finland
Atrioventricular duct
+∞
9.4
9
*
Q23.0
ICD-10 Finland
Congenital stenosis of aortic valve
+∞
9.4
9
*
FHB50
NOMESCO Finland
Transatrial closure of VSD using patch
+∞
9.4
9
*
FFC22
NOMESCO Finland
Percutaneous transluminal closure of ostium secundum type ASD
+∞
9.4
9
*
XQ903
NOMESCO Finland
Production of other scan or drawing
+∞
9.4
9
*
Q23.3
ICD-10 Finland
Congenital mitral insufficiency
+∞
9.4
9
*
7455A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect
+∞
9.4
9
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
6.7
9.0
22
35
602
Kela drug reimbursment
Children's severe malnutrition
6.3
9.0
23
39
WZC30
NOMESCO Finland
Teaching
3.7
8.7
39
119
ZX199
NOMESCO Finland
Other rote
12.1
8.7
15
13
XF640
NOMESCO Finland
NA
20.8
8.5
12
6
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.4
8.5
87
447
AEX
HP
Other pulmonary or pulmonary artery valve procedure
+∞
8.4
8
*
FGB10
NOMESCO Finland
Repair of Ebstein's anomaly with mobilisation and ventricular plication
+∞
8.4
8
*
Q21.3
ICD-10 Finland
Tetralogy of Fallot
+∞
8.4
8
*
Q20.40
ICD-10 Finland
Double inlet left ventricle
+∞
8.4
8
*
7461A
ICD-9 Finland
Other congenital anomalies of heart, Tricuspid atresia and stenosis, congenital[VITIUM VALVULAE TRICUSPIDALIS CONGENITUM CUM ATRESI]
+∞
8.4
8
*
FAE00
NOMESCO Finland
Anastomosis to pulmonary artery from superior vena cava
+∞
8.4
8
*
Q26.1
ICD-10 Finland
Persistent left superior vena cava
+∞
8.4
8
*
74734
ICD-8 Finland
Other congenital anomalies of circulatory system, Stenosis, hypoplasia sive aplasia arteriae pulmonalis
+∞
8.4
8
*
Q21.0
ICD-10 Finland
Ventricular septal defect
+∞
8.4
8
*
ZSF00
NOMESCO Finland
Procedure related to previous procedure classified in chapter F
+∞
8.4
8
*
C07AB07
ATC
bisoprolol; oral
2.6
8.3
70
327
B01AB05
ATC
enoxaparin; parenteral
2.9
8.3
54
217
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
34.4
8.1
10
*
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
34.4
8.1
10
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
8.1
66
301
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.6
8.0
36
111
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
4.4
8.0
28
69
WX704
NOMESCO Finland
Intubation
4.6
7.8
26
61
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
46.3
7.8
9
*
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
19.0
7.7
11
6
I47.2
ICD-10 Finland
Ventricular tachycardia
12.3
7.7
13
11
74642
ICD-8 Finland
Congenital anomalies of heart, Defectus septi atriorum, ostium secundum
82.1
7.4
8
*
WX402
NOMESCO Finland
General anaesthesia
2.4
7.4
69
336
Q24.0
ICD-10 Finland
Dextrocardia
+∞
7.3
7
*
74654
ICD-8 Finland
Congenital anomalies of heart, Maleformatio valvulae tricuspidalis (morbus Ebstein incluso)
+∞
7.3
7
*
Q20.5
ICD-10 Finland
Discordant atrioventricular connection
+∞
7.3
7
*
7452A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Tetralogy of Fallot[TETRALOGIA FALLOT]
+∞
7.3
7
*
FAE10
NOMESCO Finland
Bidirectional anastomosis between superior vena cava and pulmonary artery
+∞
7.3
7
*
Q20.8
ICD-10 Finland
Other congenital malformations of cardiac chambers and connections
+∞
7.3
7
*
FGC10
NOMESCO Finland
Annuloplasty of tricuspid valve using prosthetic ring
+∞
7.3
7
*
FHE30
NOMESCO Finland
Repair of tetralogy of Fallot with transannular patch
+∞
7.3
7
*
Q22.8
ICD-10 Finland
Other congenital malformations of tricuspid valve
+∞
7.3
7
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
7.3
48
192
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
12.5
7.1
12
10
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
41.1
6.8
8
*
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
41.1
6.8
8
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
6.7
51
223
WX002
NOMESCO Finland
Sedation and analgesia
2.6
6.6
48
206
FM1CD
NOMESCO Finland
Very extensive CT of heart
71.4
6.4
7
*
I49.5
ICD-10 Finland
Sick sinus syndrome
14.7
6.4
10
7
7460B
ICD-9 Finland
Other congenital anomalies of heart, Anomalies of pulmonary valve[VITIUM VALVULAE PULMONALIS CONGENITUM CUM ATRESIA]
+∞
6.3
6
*
Q23.4
ICD-10 Finland
Hypoplastic left heart syndrome
+∞
6.3
6
*
FXA20
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure
+∞
6.3
6
*
Q21.31
ICD-10 Finland
Tetralogy of Fallot and double outlet right ventricle
+∞
6.3
6
*
7462A
ICD-9 Finland
Other congenital anomalies of heart, Ebstein's anomaly[ANOMALIA EBSTEIN]
+∞
6.3
6
*
FBJ00
NOMESCO Finland
Anastomosis to pulmonary artery from subclavian artery
+∞
6.3
6
*
7451B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Transposition of great vessels[DOUBLE OUTLET RIGHT VENTRICLE]
+∞
6.3
6
*
74629
ICD-8 Finland
Congenital anomalies of heart, Tetralogy of Fallot
+∞
6.3
6
*
Q25.40
ICD-10 Finland
Aortic hypoplasia
+∞
6.3
6
*
5253
FHL
Cardiac lung machine
+∞
6.3
6
*
Q21.18
ICD-10 Finland
Other spedified atrial septal defect
+∞
6.3
6
*
FPH00
NOMESCO Finland
Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator
+∞
6.3
6
*
Q24.9
ICD-10 Finland
Congenital malformation of heart, unspecified
+∞
6.3
6
*
5504
FHL
Subclavian pulmonary anastomosis (Blalock)
+∞
6.3
6
*
Q24.8
ICD-10 Finland
Other specified congenital malformations of heart
+∞
6.3
6
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
5.1
6.2
18
37
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
12.9
6.1
10
8
R07.4
ICD-10 Finland
Chest pain, unspecified
2.4
6.1
52
240
I50.9
ICD-10 Finland
Heart failure, unspecified
5.0
6.0
18
38
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
123
68
31.56
163.69
6.5
5.4
ng/l
155.5
130.5
0.20
117
60
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
187
281
18.15
138.78
9.1
4.4
ng/l
673.8
741.0
0.21
182
229
(3018677) aPTT in Platelet poor plasma by Coagulation assay
123
286
6.90
55.25
9.2
6.5
s
32.4
30.4
1.32
123
281
(3032080) INR in Blood by Coagulation assay
162
522
6.02
50.03
14.5
6.4
inr
1.5
1.1
2.68
30
171
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
41
32
14.85
43.53
3.2
8.1
%
78.8
98.7
2.56
41
32
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
104
268
5.59
40.25
7.3
2.8
ng/l
2042.5
592.2
1.48
88
150
(3033658) Prothrombin time (PT) actual/Normal
145
502
4.93
39.00
11.6
7.0
%
74.0
91.0
13.05
145
494
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
40
38
12.12
37.52
25.4
21.8
u/ml
0.3
0.3
0.50
30
24
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
131
436
4.78
36.64
3.6
3.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
139
551
4.03
29.36
3.8
3.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
35
45
8.75
26.13
1.5
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
40
64
7.13
24.73
23.2
18.8
mmol/l
24.8
24.3
0.42
40
64
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
166
852
3.34
21.65
4.6
4.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
45
94
5.52
21.19
2.0
2.6
ug/l
32.2
7.3
2.10
39
83
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
37
64
6.51
21.16
23.2
24.3
—
—
—
0
0
(3044889) 12 lead EKG panel
188
1064
3.35
20.32
5.4
2.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
99
410
3.19
17.93
5.5
3.7
mg/l
1.4
1.1
0.50
75
301
(3024928) Oxygen saturation in Venous blood
24
34
7.63
16.37
6.0
27.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
48
134
4.12
15.72
20.8
14.8
mmol/l
1.1
0.9
0.10
42
111
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
70
258
3.29
15.13
4.8
2.9
%
23.3
23.8
0.10
64
234
(3042936) Bacteria identified in Isolate by Culture
66
235
3.37
15.09
2.6
2.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
18
21
9.09
14.29
1.4
2.0
%
116.3
99.3
0.66
18
21
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
36
88
4.55
13.95
25.8
14.6
%
0.7
0.7
0.21
36
88
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
36
88
4.55
13.95
25.8
14.6
%
1.1
1.4
2.20
36
88
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
16
17
9.92
13.56
1.5
2.1
%
148.4
114.2
1.24
16
17
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
150
874
2.55
13.23
11.1
7.3
umol/l
18.2
20.2
0.38
143
818
(3004789) Transferrin [Mass/volume] in Serum or Plasma
70
278
3.03
13.19
4.8
2.8
g/l
2.5
2.5
0.23
70
260
(3023368) Bacteria identified in Blood by Culture
90
411
2.76
13.09
5.6
4.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
16
5
33.79
12.71
2.4
13.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
16
6
28.14
12.18
2.4
11.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
17
24
7.48
11.55
4.5
35.4
%
12.8
10.8
1.35
17
24
(3019230) Fractional oxyhemoglobin in Venous blood
20
34
6.26
11.49
6.2
25.8
%
72.9
70.3
0.31
20
34
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
25
55
4.89
10.95
2.8
1.6
g/l
1.1
1.3
0.43
20
50
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
91
469
2.40
9.91
4.2
3.2
ng/l
51.5
21.0
0.88
54
237
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
102
553
2.33
9.89
3.5
3.2
mg/l
3.2
2.7
0.63
93
480
(40758558) Short blood count panel - Blood
121
715
2.22
9.46
7.1
9.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
78
384
2.43
9.34
20.2
16.0
mmol/l
25.4
24.7
1.26
78
384
(3000991) Gas panel - Venous blood
71
337
2.48
9.19
21.2
11.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
257
2110
3.76
9.18
28.0
13.1
mmol/l
139.3
139.5
1.05
257
2043
(3023103) Potassium [Moles/volume] in Serum or Plasma
257
2111
3.76
9.16
28.3
13.1
mmol/l
4.0
3.9
1.40
257
2037
(3022313) Gas panel - Capillary blood
66
305
2.52
9.03
16.3
10.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
143
917
2.15
8.95
9.5
9.7
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
11
13
8.77
8.52
1.4
1.1
%
86.0
101.5
0.72
11
13
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
60
274
2.52
8.37
2.7
2.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
172
1205
2.11
8.30
9.3
9.1
%
2.8
3.0
0.33
163
1150
(3013512) EKG study
72
362
2.33
8.11
5.3
3.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
11
5
22.81
8.08
1.5
1.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
172
1215
2.08
8.00
9.4
9.3
%
9.1
8.3
2.95
164
1168
(3000494) Fungus identified in Specimen by Culture
49
207
2.66
7.99
1.9
1.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
168
1179
2.07
7.92
9.3
9.2
%
0.5
0.7
3.15
161
1127
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
69
348
2.31
7.68
17.1
10.5
mmol/l
2.0
0.8
3.52
58
258
(3013826) Glucose [Moles/volume] in Serum or Plasma
170
1207
2.05
7.66
13.2
7.0
mmol/l
5.9
6.2
2.17
164
1109
(3002030) Lymphocytes/100 leukocytes in Blood
176
1266
2.06
7.64
9.2
9.0
%
27.2
33.9
11.68
168
1218
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
69
352
2.28
7.46
17.3
10.4
kpa
5.2
5.0
1.40
69
333
(40761511) CBC panel - Blood by Automated count
268
2330
4.81
7.31
19.6
9.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
46
197
2.60
7.28
2.7
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
46
198
2.58
7.21
2.8
2.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
5
20.66
7.18
1.4
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
177
1297
2.00
7.03
10.1
9.6
e9/l
0.2
0.2
0.48
163
1116
(3006315) Basophils [#/volume] in Blood
173
1261
1.98
6.94
9.4
8.9
e9/l
0.0
0.0
0.48
159
1062
(3018010) Neutrophils/100 leukocytes in Blood
171
1243
1.97
6.90
9.2
8.9
%
58.3
51.3
11.39
163
1198
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
139
947
1.93
6.75
22.4
11.8
mmol/l
1.2
1.2
3.18
134
895
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
24
74
3.45
6.73
2.0
2.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
147
1022
1.93
6.70
18.6
11.2
mmol/l
1.2
1.2
1.86
137
915
(3001604) Monocytes [#/volume] in Blood
172
1261
1.95
6.67
9.4
8.9
e9/l
0.6
0.6
1.78
158
1062
(3002385) Erythrocyte distribution width [Ratio]
251
2126
2.80
6.63
30.5
15.6
%
13.6
13.3
2.96
251
2095
(3019198) Lymphocytes [#/volume] in Blood
175
1304
1.92
6.31
9.4
8.9
e9/l
1.7
2.2
12.19
163
1133
(3015235) Bicarbonate [Moles/volume] in Capillary blood
20
57
3.70
6.28
11.5
12.1
mmol/l
22.3
23.6
1.31
20
50
(3007853) Bacteria identified in Skin by Aerobe culture
53
259
2.29
6.28
2.4
1.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
68
369
2.11
6.22
10.0
10.6
mmol/l
1.7
1.1
1.34
62
287
(3042733) HLA Ab [Presence] in Serum
11
19
5.99
6.15
3.4
2.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
21
63
3.52
6.13
2.7
2.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
199
1556
1.97
6.11
16.0
8.7
ml/min/173m2
98.2
96.3
0.44
161
1163
(3002256) Pathology report gross observation
41
182
2.47
6.00
1.5
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
52
258
2.25
5.93
6.2
6.4
umol/l
8.4
8.1
0.05
47
208
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
23
75
3.25
5.92
2.0
2.5
—
—
—
0
0
(4268621)
13
28
4.82
5.80
2.3
2.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
9
7
13.23
5.62
1.1
1.9
umol/l
12.2
11.7
—
9
7
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
17
47
3.79
5.57
1.6
2.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
19
60
3.33
5.14
1.3
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
60
3.33
5.14
1.8
2.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
181
1413
1.80
5.11
11.4
11.6
e9/l
3.8
3.7
0.32
166
1202
(3024471) HLA-A [Type]
11
23
4.94
5.06
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
11
23
4.94
5.06
1.0
1.2
—
—
—
0
0
(4306422)
13
32
4.21
4.95
1.3
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
145
1086
1.70
4.53
4.3
3.1
ug/l
80.0
67.2
0.62
139
1018
(3051611) Lipemic interference index of Serum or Plasma
12
30
4.13
4.48
2.7
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
16
50
3.33
4.41
1.9
2.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
40
3.63
4.39
1.3
1.1
—
—
—
0
0
(44790048)
16
51
3.27
4.28
2.1
2.5
—
—
—
0
0
(44806118)
16
51
3.27
4.28
2.1
2.5
—
—
—
0
0
(44790047)
16
51
3.27
4.28
2.1
2.5
—
—
—
0
0
(44790049)
16
51
3.27
4.28
2.1
2.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
255
2281
2.37
4.14
23.1
11.7
mg/l
25.1
21.3
1.17
215
1626
(3003694) ABO and Rh group [Type] in Blood
101
702
1.69
4.07
1.7
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
67
415
1.81
4.04
3.4
3.2
mosm/kgh2o
561.0
570.9
0.12
57
349
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
48
3.25
3.99
2.0
4.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
256
2306
2.34
3.87
31.3
14.1
%
39.5
40.0
0.53
231
1981
(3051651) Icteric interference index of Serum or Plasma
10
26
3.95
3.55
2.6
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
86
592
1.65
3.52
3.8
3.0
mmol/l
2.4
2.4
0.15
80
538
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
36
3.44
3.52
4.7
4.2
%
57.4
52.7
0.46
12
36
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
25
114
2.31
3.47
2.6
2.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
37
3.34
3.38
1.5
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
123
2.23
3.32
1.3
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
25
117
2.25
3.27
2.6
2.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
152
1214
1.55
3.25
12.6
11.0
e9/l
0.0
0.0
0.40
132
946
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
33
3.43
3.22
1.5
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
108
802
1.57
3.18
4.5
4.8
e6/l
16.9
42.5
1.72
77
537
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
13
44
3.05
3.18
1.3
1.2
u/ml
3.9
2.9
—
7
20
(3021901) Oxygen saturation in Capillary blood
12
39
3.17
3.13
7.3
8.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
59
865
0.60
3.10
1.5
1.7
u/ml
0.8
2.7
2.03
17
158
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
7
12
5.95
3.04
1.3
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
21
4.39
3.02
1.8
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
100
737
1.56
3.02
4.4
4.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
57
2.72
3.01
10.8
14.9
—
2738.2
—
0
9
(3020393) Adenovirus Ag [Presence] in Stool
11
35
3.23
2.96
1.2
2.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
91
664
1.55
2.84
4.2
4.2
e6/l
28.0
41.0
0.42
73
504
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
36
3.14
2.84
5.0
4.1
e9/l
4.2
3.5
0.42
11
36
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
48
2.79
2.76
2.2
2.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
14
5.10
2.74
2.3
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
20
94
2.21
2.62
2.1
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
85
623
1.52
2.57
4.2
4.0
e6/l
0.5
0.3
0.52
70
463
(1175426) CD3 cells/100 lymphocytes in Blood
13
50
2.68
2.57
1.9
4.8
%
40.7
67.7
2.22
13
50
(3023520) Reticulocytes [#/volume] in Blood
34
197
1.83
2.53
6.8
4.5
e9/l
75.4
65.2
0.52
23
131
(3000850) Epithelial cells [#/volume] in Urine
64
442
1.58
2.51
4.0
3.2
e6/l
5.7
7.5
0.38
56
385
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
26
3.54
2.50
1.6
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
26
3.54
2.50
1.2
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
246
2256
1.76
2.46
13.4
9.0
u/l
25.2
26.3
0.55
241
2171
(3018418) pH of Serum or Plasma
69
489
1.55
2.42
5.3
3.6
ph
7.4
7.4
0.46
15
88
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
12
46
2.68
2.39
1.9
4.6
%
13.1
27.4
3.23
12
46
(3034426) Prothrombin time (PT)
5
8
6.34
2.38
1.0
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
8
6.34
2.38
1.0
2.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
84
625
1.49
2.34
4.2
4.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
23
3.55
2.28
1.6
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
18
3.96
2.26
1.4
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
25
136
1.92
2.26
1.6
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
18
87
2.14
2.22
2.2
2.6
—
—
—
0
0
(4281824)
5
9
5.63
2.22
1.0
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
74
544
1.49
2.17
2.8
2.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
15
4.06
2.05
4.5
4.6
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
15
4.06
2.05
9.2
8.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
44
2.56
2.03
1.2
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
55
385
1.53
2.03
2.7
3.7
e6/l
4.2
2.3
0.57
36
223
(3002179) Metamyelocytes/100 leukocytes in Blood
23
127
1.88
2.01
3.0
6.1
%
0.0
0.4
—
5
31
(3021440) Promyelocytes/100 leukocytes in Blood
24
135
1.85
1.98
3.6
6.5
%
0.0
0.2
—
6
41
(3011897) Casein IgE Ab [Units/volume] in Serum
0
50
0.00
1.90
0.0
1.6
—
2.9
—
0
12
(3006245) CD3-CD19+ cells/100 cells in Blood
12
52
2.37
1.90
2.1
4.8
%
43.2
14.0
2.07
12
52
(3000475) Leukocytes [#/volume] in Synovial fluid
7
22
3.24
1.89
2.3
1.6
e6/l
8438.9
7131.4
—
7
17
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
22
123
1.86
1.86
2.8
2.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
12
4.22
1.83
1.8
1.2
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
9
35
2.62
1.81
5.3
4.2
kpa
4.6
4.9
—
9
35
(3027315) Oxygen [Partial pressure] in Blood
9
35
2.62
1.81
5.3
4.2
kpa
8.5
9.4
—
9
35
(3048689) Calprotectin [Mass/mass] in Stool
30
460
0.61
1.79
2.6
3.3
ug/g
268.3
84.5
0.49
25
363
(3019309) Folate [Moles/volume] in Red Blood Cells
31
195
1.66
1.78
1.6
1.7
nmol/l
1067.7
1224.6
0.51
25
148
(3000570) Elastase.pancreatic [Mass/mass] in Stool
12
55
2.23
1.70
1.3
1.5
ug/g
217.0
292.6
—
7
28
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
63
2.12
1.62
2.1
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
20
3.04
1.59
1.2
1.8
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
20
3.04
1.59
6.7
11.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
20
3.04
1.59
1.2
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
20
3.04
1.59
1.2
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
24
146
1.70
1.57
3.6
6.2
%
0.0
0.7
—
6
47
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
37
253
1.53
1.53
1.4
1.7
pmol/l
489.4
29778262.8
0.50
31
225
(3037467) Urinalysis macro (dipstick) panel - Urine
162
1426
1.32
1.50
5.0
4.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
37
2.48
1.49
5.9
4.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
16
88
1.87
1.44
1.4
1.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
196
2120
0.75
1.39
4.4
3.9
—
—
—
0
0
(3010421) pH of Blood
9
41
2.23
1.38
5.3
3.8
ph
7.4
7.4
—
9
35
(3038515) Glucose [Moles/volume] in Venous blood
6
23
2.64
1.37
7.3
3.0
mmol/l
7.9
6.8
—
6
23
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
5
17
2.97
1.36
6.4
7.1
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
5
17
2.97
1.36
8.4
7.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
29
195
1.54
1.31
2.1
2.4
u/l
32.6
33.6
0.05
24
159
(3019060) Gas panel - Arterial blood
12
62
1.98
1.29
5.9
10.8
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
18
2.81
1.29
2.8
7.5
ug/l
22.9
20.1
—
5
18
(3023183) Ammonium ion [Moles/volume] in Plasma
12
63
1.95
1.24
2.9
4.4
umol/l
32.9
39.8
1.11
12
56
(3025159) Blasts/100 leukocytes in Blood
21
132
1.64
1.24
3.8
6.6
%
0.0
0.1
—
5
35
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
38
2.14
1.19
3.4
2.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
48
617
0.73
1.16
2.3
2.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
20
2.53
1.15
1.2
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
20
128
1.61
1.12
3.0
2.0
u/ml
167.6
155.2
0.09
15
59
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
186
1705
1.27
1.10
4.7
3.8
pmol/l
15.2
14.5
3.23
170
1572
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
59
1.90
1.09
2.3
1.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
32
2.22
1.09
6.7
5.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
33
2.15
1.06
2.0
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
60
1.87
1.04
3.1
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
50
391
1.34
1.04
2.9
3.7
e6/l
1.3
0.7
0.63
32
230
(40768804) Tissue Pathology biopsy report
80
670
1.27
1.01
2.1
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
29
0.00
0.98
0.0
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
30
0.00
0.98
0.0
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
9
50
1.83
0.97
1.0
2.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
168
1534
1.24
0.97
4.2
4.2
mmol/mol
36.0
37.9
2.40
159
1445
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
31
0.00
0.97
0.0
1.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
31
0.00
0.97
0.0
1.5
—
115.0
—
0
6
(36660697) Celiac disease serology panel - Serum
27
369
0.70
0.95
1.3
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
51
1.79
0.95
1.6
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
55
1.85
0.93
1.2
1.6
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
6
28
2.17
0.92
7.3
2.7
mmol/l
1.5
1.3
—
6
28
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
28
2.17
0.92
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
63
1.78
0.91
1.3
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
128
0.54
0.90
1.6
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
16
239
0.65
0.89
2.8
1.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
30
2.02
0.87
1.2
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
32
240
1.38
0.87
2.3
2.3
mmol/l
2.4
2.4
0.22
26
204
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
19
131
1.48
0.81
2.9
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
17
244
0.68
0.79
2.9
1.9
—
—
—
0
0
(4062490)
6
33
1.84
0.79
1.5
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
21.4
—
1194.7
—
0
25
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
12.1
—
689.8
—
0
25
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
0
26
0.00
0.79
0.0
2.0
—
2.9
—
0
20
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
27
0.00
0.78
0.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
254
0.69
0.77
1.2
1.1
—
—
—
0
0
(4035726)
20
141
1.45
0.77
3.3
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
17
242
0.68
0.76
2.7
1.9
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
9
54
1.69
0.75
1.2
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
136
0.58
0.75
1.0
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
210
1989
1.23
0.74
5.3
4.2
mu/l
2.1
1.9
1.69
200
1852
(3001019) Free T4 and TSH panel - Serum or Plasma
6
106
0.56
0.74
1.8
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
17
240
0.69
0.74
2.7
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
157
0.62
0.71
1.2
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
58
488
1.24
0.71
6.1
5.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
42
1.68
0.69
1.7
1.9
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
7
42
1.68
0.69
2.4
4.0
u/ml
23.4
5.1
—
7
37
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
27
1.87
0.69
4.4
6.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
48
574
0.80
0.68
1.9
2.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
44
531
0.80
0.68
1.8
2.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
18
247
0.71
0.67
1.2
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
7
43
1.64
0.67
1.9
3.6
—
572.1
—
0
7
(40761536) Microorganisms panel - Urine sediment
23
172
1.37
0.66
4.9
3.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
11
163
0.66
0.62
3.5
2.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
141
0.63
0.62
1.1
1.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
72
1.55
0.60
1.3
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
72
1.55
0.60
1.1
2.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
22
0.00
0.59
0.0
8.9
—
52.6
—
0
5
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
21
274
0.75
0.59
1.3
1.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
28
221
1.30
0.58
1.6
1.4
u/ml
238.3
335.4
0.32
28
206
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
54
1.50
0.58
1.6
1.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
74
1.51
0.54
1.5
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
74
1.51
0.54
1.5
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
203
0.72
0.54
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
17
225
0.74
0.53
2.6
1.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
66
1.53
0.53
1.1
2.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
163
1538
1.14
0.49
6.2
4.2
mm/h
8.6
8.7
0.06
158
1423
(3003888) Timothy IgE Ab [Units/volume] in Serum
12
166
0.71
0.49
1.1
1.3
u/ml
10.3
6.6
—
7
128
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
182
1733
1.14
0.47
3.8
3.7
mmol/l
2.7
2.8
0.71
167
1609
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
49
562
0.84
0.47
1.8
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
141
0.70
0.46
1.2
1.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
163
0.72
0.45
1.0
1.3
u/ml
3.2
1.4
—
7
119
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
16
207
0.76
0.44
1.7
2.0
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
11
78
1.43
0.43
11.1
5.7
%
47.2
51.6
0.25
11
78
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
31
1.62
0.43
1.0
2.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
27.0
—
0.6
—
0
15
(3017143) Hepatitis C virus Ab [Presence] in Serum
41
354
1.19
0.41
1.4
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
16
0.00
0.41
0.0
1.8
—
13.1
—
0
16
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.4
—
19.3
—
0
6
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.4
—
24.2
—
0
5
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
8.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
35
298
1.20
0.41
3.5
2.8
nmol/l
357.7
346.5
0.13
30
284
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
73
802
0.88
0.40
1.9
1.7
g/l
1.9
1.9
0.07
52
412
(3025130) Human papilloma virus identified in Specimen
5
35
1.44
0.39
1.8
1.9
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
8.9
—
0.6
—
0
19
(1761482) Bacteria [#/volume] in Urine by Culture
5
36
1.40
0.38
1.6
3.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
16
125
1.30
0.38
1.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
190
0.78
0.37
2.9
2.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
97
901
1.12
0.36
4.1
3.0
nmol/l
71.3
71.7
0.05
92
829
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
6
42
1.44
0.36
2.0
1.5
u/l
12.4
15.0
—
6
34
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
145
0.75
0.35
1.3
1.3
—
—
—
0
0
(4034850)
6
43
1.40
0.35
5.8
6.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
24
200
1.22
0.35
1.4
1.6
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
6
86
0.69
0.33
1.0
1.0
kpa
2.7
3.1
—
6
75
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
6
87
0.68
0.33
1.0
1.0
kpa
7.7
7.3
—
6
76
(3006598) pH of Arterial cord blood
6
87
0.68
0.33
1.0
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
13
101
1.30
0.32
1.5
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
180
1735
1.11
0.32
3.7
3.5
mmol/l
4.3
4.6
2.54
171
1625
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
203
1.20
0.31
1.3
1.2
iu/ml
106.3
147.3
—
10
67
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
171
1647
1.10
0.30
3.6
3.2
mmol/l
1.2
1.2
0.01
159
1529
(3023511) Choriogonadotropin [Units/volume] in Urine
8
107
0.74
0.29
1.6
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
67
726
0.90
0.29
3.8
3.2
—
—
—
0
0
(3020891) Body temperature
7
57
1.23
0.29
11.3
5.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
151
0.79
0.29
1.3
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
172
0.80
0.28
2.1
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
8
63
1.28
0.28
1.8
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
63
1.28
0.28
2.8
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
72
1.26
0.26
1.8
1.6
—
—
—
0
0
(3000492) Spirometry study
24
208
1.17
0.25
1.5
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
15
179
0.83
0.24
1.1
1.3
u/ml
23.9
2.9
—
10
116
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
33
296
1.13
0.22
1.6
1.4
titre
400.0
416.5
—
10
46
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
41
1.22
0.22
1.6
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
32
355
0.89
0.21
4.1
4.1
mg/mmol
28.0
13.6
0.50
19
242
(40768797) Stomach Pathology biopsy report
26
230
1.14
0.21
1.3
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(4024509)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
11
0.00
0.21
0.0
5.5
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
10
0.00
0.21
0.0
5.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
8
104
0.76
0.21
2.1
1.9
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
20.5
—
0
12
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.5
—
95.3
—
0
12
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
1416.0
—
0
12
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
7.8
—
0
6
(3019832) Treponema pallidum Ab [Presence] in Serum
40
437
0.90
0.21
1.5
1.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
26
231
1.14
0.20
2.7
1.8
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
9
112
0.80
0.20
1.0
1.0
mu/l
8.1
8.3
—
9
102
(3045462) Protein/Creatinine [Ratio] in Urine
6
48
1.26
0.20
3.0
7.8
g/mol
46.5
83.0
—
6
43
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
4.7
—
86.9
—
0
14
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
173
1686
1.07
0.19
2.8
3.2
mmol/l
5.4
5.6
1.39
164
1549
(3028707) Methadone [Presence] in Urine by Screen method
10
121
0.82
0.18
3.0
2.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
176
1718
1.07
0.18
3.7
3.4
mmol/l
1.3
1.4
2.25
164
1596
(3032773) Endomysium IgG Ab [Titer] in Serum
5
68
0.73
0.17
1.2
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
8
70
1.15
0.16
1.4
2.4
u/l
37.8
40.6
—
8
64
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
28
307
0.90
0.16
1.2
1.3
u/ml
4.1
8.2
—
8
113
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
76
0.78
0.16
1.0
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
6
77
0.77
0.16
1.7
1.8
nmol/l
1.9
0.5
—
6
66
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
79
0.75
0.15
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
80
0.74
0.15
1.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
83
1.09
0.15
1.3
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
15
170
0.88
0.14
2.9
3.5
%
33.3
31.7
—
9
117
(3019225) pH of Specimen
14
122
1.16
0.14
7.8
5.1
—
—
—
0
0
(3015736) pH of Urine
77
802
0.94
0.13
3.4
3.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
113
1.16
0.13
1.0
1.1
—
—
—
0
0
(4010399)
13
114
1.15
0.12
1.6
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
15
167
0.89
0.11
3.8
2.0
iu/l
13.2
13.3
0.00
15
121
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
5
45
1.11
0.10
3.2
2.3
nmol/l
0.2
0.1
—
5
33
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
114
0.87
0.09
1.5
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
97
1.14
0.09
1.4
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
57
549
1.05
0.08
1.8
1.6
pmol/l
84.3
98.5
1.66
33
274
(3035350) Ketones [Presence] in Urine by Test strip
101
986
1.04
0.08
3.6
3.4
estimate
0.0
0.0
0.00
23
170
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
61
0.82
0.08
1.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
13
117
1.12
0.08
5.4
3.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
52
501
1.05
0.08
4.5
3.5
estimate
0.0
0.0
0.50
23
175
(3009508) Creatinine [Moles/volume] in Urine
55
569
0.96
0.07
3.6
4.2
mmol/l
6.4
8.0
1.80
50
519
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
81
0.86
0.07
1.1
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
82
0.85
0.07
1.3
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
84
1.07
0.07
1.3
1.1
—
—
—
0
0
(1002224) Polysomnography panel
9
85
1.06
0.07
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
33
346
0.95
0.07
3.1
3.4
mg/l
165.5
114.4
0.24
18
245
(46235355) HIV 1 and 2 tests - Meaningful Use set
66
679
0.96
0.07
1.9
2.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
88
1.02
0.07
1.4
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
92
0.87
0.07
1.3
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
94
0.85
0.07
2.0
1.6
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
15
162
0.92
0.06
1.0
1.2
u/ml
3.6
5.0
—
6
54
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
87
886
0.97
0.05
1.8
1.9
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
130
1.08
0.04
1.3
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
55
537
1.03
0.04
3.2
2.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
32
331
0.96
0.04
1.4
2.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
55
538
1.03
0.03
1.6
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
37
359
1.04
0.03
1.4
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
49
500
0.98
0.02
3.6
3.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
100
989
1.02
0.02
4.8
4.9
estimate
0.0
0.0
0.00
24
180
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
14
148
0.94
0.02
6.1
5.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
12
113
1.06
0.02
2.1
2.5
ug/l
0.4
0.8
—
5
61
(3022145) Colonoscopy Study observation
18
173
1.04
0.01
1.2
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
94
1.07
0.01
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
94
1.07
0.01
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
118
1.02
0.00
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
118
1.02
0.00
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
118
1.02
0.00
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
118
1.02
0.00
1.3
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
15
148
1.01
0.00
1.3
1.2
—
31.0
—
0
5
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
121
0.99
0.00
1.4
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
32
317
1.01
0.00
1.3
1.2
iu/ml
15.7
27.6
—
10
83
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
23
233
0.99
0.00
1.3
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
10
96
1.04
0.00
1.0
1.1
u/ml
11.5
8.6
—
5
54
(3014133) Dog dander IgE Ab [Units/volume] in Serum
11
106
1.04
0.00
1.0
1.1
u/ml
8.8
9.0
—
5
57
(3009261) Glucose [Presence] in Urine by Test strip
100
995
1.01
0.00
3.7
3.4
estimate
0.0
0.0
0.00
24
172
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
134
1345
0.99
0.00
4.9
3.8
u/l
51.2
35.4
1.96
128
1295
(3036048) Francisella tularensis Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
4.6
—
—
—
0
0
(4038314)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
7
70
1.00
0.00
2.3
2.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
56
0.89
0.00
1.4
1.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009410) PHENobarbital [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.6
—
108.0
—
0
7
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
130
1.00
0.00
1.3
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.6
—
24.3
—
0
8
(3013727) Leukocytes other/100 leukocytes in Blood
0
8
0.00
0.00
0.0
10.0
—
48.6
—
0
8
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
6.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
17.7
—
0
5
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.1
—
129.8
—
0
8
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
6.0
—
4.1
—
0
7
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
54
0.92
0.00
1.2
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
7
0.00
0.00
0.0
5.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
77
0.91
0.00
2.0
1.7
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
0
5
0.00
0.00
0.0
2.6
—
1.7
—
0
5
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_PULMONARY_TRICU_VALVES and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_PULMONARY_TRICU_VALVES | 3.441 [2.43, 4.87] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.268 |
During the follow-up period (1.1.1998 — 31.12.2019), 91 out of 1682 females with Q17_CONGEN_MALFO_PULMONARY_TRICU_VALVES died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_PULMONARY_TRICU_VALVES | 4.147 [3.13, 5.5] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.013 |
During the follow-up period (1.1.1998 — 31.12.2019), 89 out of 1349 males with Q17_CONGEN_MALFO_PULMONARY_TRICU_VALVES died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_PULMONARY_TRICU_VALVES.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.287% | 0.541% |
| 5 | 2.239% | 5.113% |
| 10 | 5.248% | 12.434% |
| 15 | 9.974% | 22.743% |
| 20 | 16.615% | 36.333% |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_PULMONARY_TRICU_VALVES – Congenital malformations of pulmonary and tricuspid valves
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data